³í¹®) Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia °¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø Ç÷¾×º´¿ø Á¶º´½Ä ±³¼ö(»çÁø ñ§, Ç÷¾×³»°ú, °øµ¿ ±³½ÅÀúÀÚ), À¯ÀüÁø´Ü°Ë»ç¼¾ÅÍÀå ±è¸í½Å ±³¼ö(éÓ, Áø´Ü°Ë»çÀÇÇаú, °øµ¿ ±³½ÅÀúÀÚ) ¿¬±¸ÆÀ